Skip to main content
International Journal of Reproductive Biomedicine logoLink to International Journal of Reproductive Biomedicine
. 2018 Jul;16(7):455–458.

The association between estradiol levels and cognitive function in postmenopausal women

Soheila Gholizadeh 1, Shahideh Jahanian Sadatmahalleh 1, Saeideh Ziaei 1
PMCID: PMC6129375  PMID: 30234186

Abstract

Background:

Levels of estradiol decreases as women arrive the menopausal transition and enter to a low, steady level during the early postmenopause. In addition, memory dysfunction are highly prevalent during this period.

Objective:

Our study was designed to determine whether endogenous levels of estradiol are related to cognitive function in postmenopausal.

Materials and Methods:

The cross-sectional study was conducted between November 2015 to February 2016 on 209 healthy postmenopausal women. The women filled out the Montreal Cognitive Assessment (MoCA) scale. Then, estradiol level was tested for association with cognitive function adjusted for factors supposed to confound this association.

Results:

The prevalence of cognitive dysfunction; MoCA points ≤26 in our participants was 62.7%, and mean±SD of estradiol level was 14.92±10.24pg/ml in participants with cognitive dysfunction in comparison with 21.67±14.92pg/ml in those with normal cognitive function (p<0.001). There were significant association between MoCA points with estradiol level (p<0.001) and educational status (p<0.001).

Conclusion:

Estradiol replacement therapy in postmenopausal women with low endogenous estradiol levels and decreased cognitive function might be necessary.

Key Words: Cognitive function, Estradiol level, Menopause

Introduction

As women arrive in the menopausal transition and during the early postmenopausal stage circulating levels of estradiol diminishes. Memory dysfunction is highly common during this period (1-3). While this topic remains one of ongoing debate, the basic question of whether endogenous serum of estradiol influence cognitive function remains unknown. "In older postmenopausal women, relatively higher serum estradiol levels have been associated with the better memory and global cognitive function, (4) episodic memory, (5, 6) and executive function; (7) however, there are not consistent (8, 9)." Low estrogen levels associated with Alzheimer’s disease risk in late postmenopause women, (10) however again these findings are controversial (11, 12). Few studies have determined potential links between cognitive function and serum estrogens levels in early postmenopausal women, although this period is the time when women are most likely to use hormone replacement therapy. Moreover, in this age group, studies have not found significant relations between estradiol levels and cognitive function (13, 14).

The objective of the present study was to consider whether endogenous levels of estradiol are associated with cognitive function in postmenopausal women who do not use hormone therapy.

Materials and methods

The cross-sectional study was conducted on 209 healthy postmenopausal women referred to Arash Hospital, Tehran, Iran, between November 2015 to February 2016. Sample size was calculated using coefficient 99%, power level set at 0.95, and the correlation coefficient set to detect 0.31 Pearson’s r between estradiol levels and total MoCA points. The estimated, minimum sample size was 189 participants. Thus, 209 consecutive postmenopausal women who had inclusion criteria were recruited for the study. Inclusion criteria were: 1) age: 45-65 yr, 2) intact uterus and at least one ovary, 3) menstruation interruption for at least 1 yr and not more than 10 yr, 4) serum FSH concentration over 40 IU/ml, 5) no use of hormone therapy during past six months, 6) no chronic diseases such as cancer, diabetes, hypertension, cardiovascular diseases and psychiatric diseases, 7) and no smoking.

The women filled out the MoCA (Montreal Cognitive Assessment) scale and a questionnaire containing personal data. Venous blood sample were collected in the morning after an overnight fast from the women. Levels of estradiol were estimated using electrochemiluminescence method. Then, estradiol level was tested for association with cognitive function adjusted for factors supposed to confound this association.

The MoCA was created and validated by Nasreddine and colleagues (15). It is one page 30-point test administered in approximately 10 min. The MoCA assesses several cognitive domains. The full-scale point’s range is 0-30; scores ≥26 are considered normal, while scores less than 26 are abnormal and suggestive of developing mild cognitive impairment (MCI). Psychometric properties of this scale have been studied in several studies and its validity and reliability have been confirmed (16).

Ethical consideration

The study was approved by the Ethics Committee of Tarbiat Modares University of Medical Sciences (EC# 523850) and all subjects gave written informed consent.

Statistical analysis

Estradiol levels and MoCA points were not normally distributed according to K-S test. Therefore nonparametric tests were used. First, the association between MoCA points, women age, age at menarche, age at menopause, age at first pregnancy, age at marriage, BMI and gravity with estradiol level were analyzed using Spearman Correlation test. Second, the association between educational and economic status with MoCA points were evaluated by Kruskal-Wallis test.

On stepwise multiple regression analysis, the correlation between age at first pregnancy, educational status, estradiol level, gravidity, age at marriage as independent factors, and MoCA points as a dependent factor were calculated. A 95% confidence interval (CI) was used to describe the strength of association. All statistical analyses were performed by the SPSS software (Statistical Package for the Social Sciences, version 20.0, SPSS Inc., Chicago, IL, USA). A value of p<0.05 was considered significant.

Results

The prevalence of cognitive dysfunction; MoCA points ≤26 in our participants was 62.7%, and mean±SD of estradiol level was 14.92±10.24 in participants with cognitive dysfunction in comparison with 21.67±14.92 in those with normal cognitive function. The means of age, age at menarche, age at marriage, age at first pregnancy, age at menopause, gravidity, estradiol levels, MoCA points and also socioeconomic and BMI status are shown in Table I. Table II shows the correlate between MoCA points and dependent variables of interest. MoCA points was positively associated with age at first pregnancy (p<0.001), age at marriage (p<0.001), estradiol level (p<0.001) and was negatively associated with gravidity (p<0.001).

Table I.

Demographic characteristic of the participants

Variables N (%) or Mean ± SD
Age (yr)* 56.98 ± 4.35
Age at menarche (yr)* 13.18 ± 1.37
Age at marriage (yr)* 18.41 ± 5.96
Age at first pregnancy (yr)* 19.49 ± 6.26
Age at menopause (yr)* 49.88 ± 3.62
Gravidity* 4.27 ± 1.90
BMI* 28.24 ± 4.41
Estradiol levels (pg/ml)* 17.22 ± 11.07
MoCA points* 24.41 ± 2.58
Educational status**
Primary school 39 (18.7)
Second school 130 (62.2)
University 40 (19.1)
Economic status**
Poor 70 (33.5)
Moderate 96 (45.9)
good 43 (20.6)

MoCA: Montreal cognitive assessment

BMI: Body mass index

*

Data presented as Mean±SD

**

Data presented as N (%)

Table II.

Correlation between MoCA points and interested variables*

Parameters r p-value
Age (yr) -0.091 0.188
Age at menarche (yr) 0.061 0.380
Age at marriage (yr) 0.362 <0.001
Age at first pregnancy (yr) 0.319 <0.001
Age at menopause (yr) 0.026 0.704
Gravidity -0.235 <0.001
BMI 0.006 0.933
Estradiol level (pg/ml) 0.377 <0.001

BMI: Body mass index

r: Spearman correlation

*

Spearman correlation test

The association between socioeconomic statuses with MoCA points is shown in Table III. High educated participants have more MoCA points (p<0.001). Table IV shows the correlation between estradiol levels and MoCA domains separately. Estradiol level was associated with short memory (p<0.001) attention (p<0.001), and executive domains (p<0.01). For better evaluation of the relationship between MoCA points as a dependent factor and mentioned independent factors, multiple regression analysis was conducted. There were significant association between MoCA points with estradiol level (p<0.01) and educational status (p<0.001) (Table V).

Table III.

The association between socioeconomic status with MoCA points*

MoCA points p-value
Educational status
Primary school 21.58 ± 2.19 <0.001
Secondary school 24.59 ± 2.14
University 26.45 ± 1.61
Economic status
Poor 24.14 ± 2.56 0.501
Moderate 24.47 ± 2.64
Good 24.69 ± 2.50

Data presented as mean±SD.

MoCA: Montreal cognitive assessment

*

Kruskal-wallistest

Table IV.

Correlation between estradiol level and MoCA domains*

MoCA domains r p-value Mean ± SD
Visuospatial ability domain 0.127 0.066 3.02 ± 0.77
Short memory domain 0.232 <0.001 2.89 ± 0.79
Attention domain 0.293 <0.001 5.22 ± 1.01
Language domain 0.126 0.070 4.96 ± 0.23
Executive function domain 0.305 <0.001 1.81 ± 1.20
Orientation domain 0.094 0.175 5.93 ± 0.25
Total 0.377 <0.001 24.41 ± 2.58

MoCA: Montreal cognitive assessment

r: Spearman correlation

*

Spearman correlation test

Table V.

Stepwise multiple linear regression model for MoCA points*

B SE β p-value
Constant 20.08 0.407 <0.001
Estradiol level 0.044 0.013 0.187 <0.001
Educational status 1.410 0.144 0.550 <0.001

B: Unstandardized (B) regression coefficients

SE: Standard error

β: Standardized (Beta) regression coefficients.

*

MoCA points as dependent variable, and gravidity, age at marriage, age at first pregnancy, estradiol level, and educational status as independent variables. Adjusted R2=0.621, There were no significant relationships between other variables.

Discussion

Our study, primary, investigate to determine whether endogenous levels of estradiol are related to specific domains of cognitive function in postmenopausal women. In our study, estradiol level was associated with short memory, attention, and executive MoCA domains. There is some evidence from the past 30 yr, presents that estradiol modulates cognitive function in animals and human. "The effect begins in uteri when estrogens guide the sexual differentiation of various brain regions controlling reproduction and some cognitive functions." Estrogen modulations on the nervous system continue through adulthood when gonadal hormone highly secrets. "It has been emphasized that estrogens can act at membrane receptors to activate intracellular signaling mechanisms that change cellular function." Also, some new documents show estrogens are synthesized locally in the brain and therefore rapidly change cognitive functions (17).

Secondary, we evaluated the association of cognitive function with socioeconomic status. Cognitive function positively correlated with age at first pregnancy; age at marriage and educational status, but negatively correlated with gravidity. Our findings are consistent with several studies that reported a positive correlation between cognitive function and educational status, (18, 19) but are inconsistent with those of other studies that reported significant positive correlation with age. (20, 21). Differences in the mean of participants, age and the usage of a variety of psychometric instruments may have contributed to this inconsistent finding. The mean of the participants' age in our study was 56.89±4.53 yr and they were in the early postmenopausal midlife period.

We found significant positive association between cognitive function with age at first pregnancy and age at marriage while it was negatively associated with gravidity. The cross-sectional associational research design limited the data interpretation to the correlational association between these variables. Moreover, these findings cannot be generalized across the postmenopausal community because of different cultural and religious status.

For better evaluation of the relationship between cognitive function as dependent variable and gravidity, age at marriage, age at first pregnancy, estradiol level and educational status as an independent variable, multiple linear regression analysis were conducted. There were associated between global cognitive function with estradiol level and educational status and there was no meaningful relationship between the other mentioned independent variables. Our findings are consistent with studies that reported a significant correlation between estradiol level and cognitive function, (4, 5, 7, 17) but are inconsistent with other studies that reported no relationship between them (14, 22, 23). In general, the relationship between estradiol level and cognitive function have generated very mixed findings. Age and gender of the participants, differences in study approach, insufficient sample size and the usage of a variety of psychometric instruments may explain these discrepancies.

We use MoCA for consideration of cognitive function. It is a brief cognitive screening tool with high specificity and sensitivity (87% and 90%, respectively) for detecting Mild Cognitive Impairment (MCI) as currently conceptualized in patients performing normally on mini-mental state examination (15).

Our study has some strength. This is a population-based study of participated women and analyses adjusted for a number of parameters that could potentially confound the association of cognitive function with hormone level. The results of our study support that postmenopausal women with higher levels of estradiol have less likely to discomfort from cognitive impairment and clinicians should evaluate the possibility of low estradiol level as a helping factor in postmenopausal women with decreased cognitive function.

Conclusion

The present observations suggest that estradiol replacement in postmenopausal women with low endogenous estradiol levels might be necessary.

Acknowledgments

We gratefully thank the participating women. This study was funded by Tarbiat Modares University, Tehran, Iran.

Conflict of interest

The authors have no conflicts of interest.

References

  • 1.Henderson VW. Cognitive symptoms and disorders in the midlife women. Female Patient. 2011;36:1–5. [Google Scholar]
  • 2.Etgen T, Sander D, Bickel H, Forstl H. Mild cognitive impairment and dementia: the importance of modifiable risk factors. Dtsch Arztebl Int. 2011;108:743–750. doi: 10.3238/arztebl.2011.0743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Sturdee DW, Pines A, International Menopause Society Writing G, Archer DF, Baber RJ, Barlow D, et al. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric. 2011;14:302–320. doi: 10.3109/13697137.2011.570590. [DOI] [PubMed] [Google Scholar]
  • 4.Lebrun CE, van der Schouw YT, de Jong FH, Pols HA, Grobbee DE, Lamberts SW. Endogenous oestrogens are related to cognition in healthy elderly women. Clin Endocrinol(Oxf) 2005;63:50–55. doi: 10.1111/j.1365-2265.2005.02297.x. [DOI] [PubMed] [Google Scholar]
  • 5.Ryan J, Stanczyk FZ, Dennerstein L, Mack WJ, Clark MS, Szoeke C, et al. Hormone levels and cognitive function in postmenopausal midlife women. Neurobiol Aging. 2012;33:1138–1147. doi: 10.1016/j.neurobiolaging.2012.04.011. [DOI] [PubMed] [Google Scholar]
  • 6.Hogervorst E, De Jager C, Budge M, Smith AD. Serum levels of estradiol and testosterone and performance in different cognitive domains in healthy elderly men and women. Psychoneuroendocrinology. 2004;29:405–421. doi: 10.1016/s0306-4530(03)00053-2. [DOI] [PubMed] [Google Scholar]
  • 7.Wolf OT, Kirschbaum C. Endogenous estradiol and testosterone levels are associated with cognitive performance in older women and men. Horm Behav. 2002;41:259–266. doi: 10.1006/hbeh.2002.1770. [DOI] [PubMed] [Google Scholar]
  • 8.Henderson VW, St John JA, Hodis HN, McCleary CA, Stanczyk FZ, Shoupe D, et al. Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis. Neurology. 2016;87:699–708. doi: 10.1212/WNL.0000000000002980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Gleason CE, Dowling NM, Wharton W, Manson JE, Miller VM, Atwood CS, et al. Effects of hormone therapy on cognition and mood in recently postmenopausal women: findings from the randomized, controlled KEEPS-cognitive and affective study. PLoS Med. 2015;12:e1001833. doi: 10.1371/journal.pmed.1001833. discussion e1001833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Hoskin EK, Tang MX, Manly JJ, Mayeux R. Elevated sex-hormone binding globulin in elderly women with Alzheimer's disease. Neurobiol Aging. 2004;25:141–147. doi: 10.1016/s0197-4580(03)00046-0. [DOI] [PubMed] [Google Scholar]
  • 11.Maki PM, Henderson VW. Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on. Climacteric. 2012;15:256–262. doi: 10.3109/13697137.2012.660613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Lethaby A, Hogervorst E, Richards M, Yesufu A, Yaffe K. Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Syst Rev. 2008:CD003122. doi: 10.1002/14651858.CD003122.pub2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Herlitz A, Thilers P, Habib R. Endogenous estrogen is not associated with cognitive performance before, during, or after menopause. Menopause. 2007;14:425–431. doi: 10.1097/01.gme.0000247019.86748.e3. [DOI] [PubMed] [Google Scholar]
  • 14.Luetters C, Huang MH, Seeman T, Buckwalter G, Meyer PM, Avis NE, et al. Menopause transition stage and endogenous estradiol and follicle-stimulating hormone levels are not related to cognitive performance: cross-sectional results from the study of women's health across the nation (SWAN) J Womens Health (Larchmt) 2007;16:331–344. doi: 10.1089/jwh.2006.0057. [DOI] [PubMed] [Google Scholar]
  • 15.Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–699. doi: 10.1111/j.1532-5415.2005.53221.x. [DOI] [PubMed] [Google Scholar]
  • 16.Emsaki G, Molavi H, Chitsaz A, Movahed Abtahi M, Asgari K. Psychometric Properties of the Montreal Cognitive Assessment (MoCA) in Parkinson's Disease Patients in Isfahan. J Isfahan Med Sch. 2011;29:1391–1400. [Google Scholar]
  • 17.Luine VN. Estradiol and cognitive function: past, present and future. Horm Behav. 2014;66:602–618. doi: 10.1016/j.yhbeh.2014.08.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Stern Y. The concept of cognitive reserve: a catalyst for research. J Clin Exp Neuropsychol. 2003;25:589–593. doi: 10.1076/jcen.25.5.589.14571. [DOI] [PubMed] [Google Scholar]
  • 19.Nejati V. Cognitive-executive functions of brain frontal lobe in aged adults. J Behav Sci. 2010;4:59–64. [Google Scholar]
  • 20.Kempler D, Teng EL, Dick M, Taussig IM, Davis DS. The effects of age, education, and ethnicity on verbal fluency. J Int Neuropsychol Soc. 1998;4:531–538. doi: 10.1017/s1355617798466013. [DOI] [PubMed] [Google Scholar]
  • 21.Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, et al. Prevalence of dementia in the united states: the aging, demographics, and memory study. Neuroepidemiology. 2007;29:125–132. doi: 10.1159/000109998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Boss L, Kang DH, Bergstrom N, Leasure JL. Endogenous sex hormones and cognitive function in the elderly. Aging Clin Exp Res. 2015;27:515–521. doi: 10.1007/s40520-014-0300-5. [DOI] [PubMed] [Google Scholar]
  • 23.Henderson VW, Guthrie JR, Dudley EC, Burger HG, Dennerstein L. Estrogen exposures and memory at midlife: a population-based study of women. Neurology. 2003;60:1369–1371. doi: 10.1212/01.wnl.0000059413.75888.be. [DOI] [PubMed] [Google Scholar]

Articles from International Journal of Reproductive Biomedicine are provided here courtesy of Shahid Sadoughi University of Medical Sciences and Health Services

RESOURCES